Previse

About Previse

Previse is dedicated to saving lives through the prediction and earlier detection of cancer, starting with esophageal cancer. Their mission focuses on developing precision medicine solutions using proprietary epigenetic biomarkers and data science to support global clinical study populations.

Products & Services

Esopredict®:A molecular test providing personalized guidance for Barrett's esophagus surveillance and treatment decisions, offering insights into the future risk of progression to esophageal cancer.

Specialties

Precision Medicine Cancer Detection Epigenetic Biomarkers Esophageal Cancer Prevention

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Grant T: - FT: Grant	A: 1800000 MR: - FA: 1.8M FAN: 1800000	D: 2024-10-22 FD: 2024-10-22	1 investors
2	RT: SBIR Grant T: - FT: SBIR Grant	A: 1800000 MR: - FA: $1.8M FAN: 1800000	D: 2023-10-12 FD: 2023-10-12	1 investors

Grant Latest

2024-10-22

$1.8M

1 investor (Pro only)

SBIR Grant 2023-10-12

$1.8M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

No team data available

Team information is not yet available for this company

Recent News

Previse Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised